Good market prospect has attracted a lot of capital inflow. According to statistics, in 2012, medical apparatus and instruments became the most attention by private equity and venture capital industry segment. Look from the investment case number, medical apparatus and instruments of the number of transactions is 2.58 times that of 2011 total medical health industry in proportion to the number of deals, up from 13.95% in 2011 to 13.95%, and transaction amount is three times as much as 2011, accounts for the proportion of total medical health industry transaction rose to 17.51% from 2.46% in 2011.
Shenzhen co-win venture investment co., LTD., chairman of Zheng Weihe said, because the IPO appear "quake lakes" phenomenon, even if meet the requirements of the securities and futures commission the dimensions of the enterprise, now apply for listing, in order to realize the IPO also have to wait until at least 2015 years. As a result, for many small medical equipment enterprises, choose by the listed company or the development of transnational mergers and acquisitions or can be considered as the key path.
In 2012, a total of 23 in the field of national YiXie mergers and acquisitions, including 17 for the international mergers and acquisitions. "Especially recent medtronic $816 million acquisition of comfort, hk $361 million stake in shenzhen first history for hk $5.9 billion acquisition of health science and technology, creation, prices are exceed market expectations, more states that m&a is medical equipment enterprise development and the importance of venture capital exit channel." Zheng Weihe said.
International giant layout is clearly visible in China, such as medtronic even late last year two YiXie domestic companies, constantly infiltration from bone to cardiovascular field. At the same time, there are many foreign company self-built factory and r&d center in China. Toshiba medical system in China set up a research and development center, Boston scientific company also signed a deal to set up factories in the pudong district of Shanghai, including production center, r&d center, training center, and clinical center.